Is this your firm? Get featured or correct your listing →
Recent changes
- Jul 2, 2026Jul 2, 2026Invested in Celea Therapeutics ($180M) Celea Therapeutics
Portfolio
1 totalRecent Investment Activity
1Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Celea Therapeutics | funding round | Participated | $180M | — | Celea Therapeutics |
Co-Investors
2Similar Firms
overlapping sector, stage or regionValue Add Research
Latest Pulse
- Jul 5, 2026Biotech VCs Are Betting Big on Single Clinical TrialsCelea Therapeutics' $180M round, Beeline Medicine's $126.3M raise and Flare Therapeutics' $85M financing show late-stage biotech investors concentrating capital into single, high-conviction trial bets rather than diversified platform plays.→
- Jul 2, 2026Celea Therapeutics Raises $180M Series B for Pulmonary Fibrosis DrugCelea Therapeutics, a clinical-stage biotech spun out of PureTech developing deupirfenidone for idiopathic pulmonary fibrosis, announced a $180 million Series B on July 2, led by RA Capital and Leaps by Bayer, with PureTech and additional unnamed.→
- Jul 2, 2026Celea Therapeutics Raises $180M to Push Lung Drug Into Phase 3PureTech-founded Celea Therapeutics raised $180 million to fund a head-to-head Phase 3 trial testing its drug deupirfenidone against the current standard of care for idiopathic pulmonary fibrosis.→
PureTech Health FAQ
What companies has PureTech Health invested in?
PureTech Health's portfolio includes Celea Therapeutics.
Who does PureTech Health co-invest with most?
In the rounds Value Add tracks, PureTech Health most often invests alongside Leaps by Bayer (1 shared deal), RA Capital (1 shared deal).
Sources & methodologyshow
Where these figures come from
- Celea Therapeuticsprimary source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.